Skip to main content
Premium Trial:

Request an Annual Quote

Leroy Hood, Alan Aderem, Inder Verma


Leroy Hood has stepped down as director of the Institute for Systems Biology. He is replaced by the institute’s co-founder and associated director Alan Aderem. Hood, a co-founder himself, will remain the ISB’s president. Aderem will define the scientific direction of the institute and oversee the integration of its various disciplines, besides leading a research group. He left the University of Washington in 2000 to co-found the ISB. Before 1996, he headed a laboratory at Rockefeller University. “Alan’s experience and determination will be invaluable internally as I focus on raising our profile, building our resources and expanding our partnership base,” Hood said in a statement. Since it was founded in 2000, the non-profit institute has grown to more than 170 staff members and has raised more than $90 million in funding.

Inder Verma has joined the scientific advisory board of NuGEN Technologies, based in San Carlos, Calif. Verma is a professor of molecular biology at the Salk Institute and an adjunct professor at the University of California, San Diego.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.